ArticleBioinformation2025
Prognostic value of modified shock index in sepsis.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a life-threatening condition requiring early diagnosis and severity assessment in the emergency department (ED) to guide timely interventions. Therefore, it is of interest to evaluate the Modified Shock Index (MSI) as a prognostic tool for sepsis and compared its sensitivity and specificity to the quick sequential organ failure assessment (qSOFA) score in 150 sepsis patients, based on Sepsis-3 guidelines. Clinical data, including MSI and qSOFA scores, were collected at admission and patient outcomes were analyzed for mortality and hospital stay duration. An MSI cut-off of 1.28 predicted mortality with high accuracy (AUC 0.946, sensitivity 91.76%, specificity 90.77%), outperforming the qSOFA score (AUC 0.840). MSI is a reliable, easy-to-use bedside tool that surpasses the quick sequential organ failure assessment score in predicting sepsis prognosis, aiding in early identification and management of high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.